Please assess the completion status of the following clinical trial:

Trial Title: Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age range 10-65 years old~* Histological confirmed ESFT~* No previous therapy~* ECOG performance status less than 2~* Life expectancy of more than 12 weeks~* Normal laboratory values: hemoglobin\>8.0g/dl, neutrophil\>2×109/L, platelet \> 80×109/L, Hb \> 80×1012/L, serum creatine \< 1×upper limitation of normal(ULN), serum bilirubin \< 1.5×ULN, ALT and AST \< 2.5×ULN~Exclusion Criteria:~* Pregnant or lactating women~* Received treatment for the disease previously~* Serious uncontrolled diseases and intercurrent infection~* The evidence of CNS metastasis and bone marrow involvement~* History of other malignancies except cured basal cell carcinoma of skin and carcinoma in-situ of uterine cervix~* History of allergy to the drugs in this trial~* Abnormal LVEF level

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).